Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$235K Buy
+754
New +$223K 0.07% 90
2016
Q2
Sell
-214
Closed -$32K 62
2016
Q1
$32K Sell
214
-716
-77% -$106K 0.06% 117
2015
Q4
$151K Buy
930
+507
+120% +$79.7K 0.14% 74
2015
Q3
$59K Buy
423
+109
+35% +$17.2K 0.1% 96
2015
Q2
$48K Sell
314
-81
-21% -$13K 0.05% 103
2015
Q1
$63K Hold
395
0.06% 94
2014
Q4
$63K Buy
+395
New +$61.5K 0.06% 96

Other funds holding AMGN

US Financial Advisors's AMGN Position: Q1 2025 in Review

US Financial Advisors opened a new position in Amgen (AMGN) in Q1 2025: 754 shares worth $235K. The stake represents 0.07% of the portfolio and ranks #90 among its holdings. This is a return to the name: US Financial Advisors previously reported a position in AMGN as recently as Q1 2016.

US Financial Advisors first reported a position in AMGN in Q4 2014 and has held it in 7 quarters since. 2,926 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

  • US Financial Advisors held 754 shares of Amgen worth $235K as of Q1 2025.
  • Amgen was a new US Financial Advisors position in Q1 2025.
  • Amgen made up 0.07% of US Financial Advisors's portfolio in Q1 2025, its #90 holding.
  • US Financial Advisors first reported a position in Amgen in Q4 2014 and has held it in 7 quarters since.
  • 2,926 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on US Financial Advisors's 13F filing for Q1 2025, filed 8 May 2025.